Back to search
FDAFDA · Food and drugs·Recall number D-0789-2022

Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.

Published May 4, 2022 · Recall initiated: April 12, 2022

Summary

FDA records drug Class II recall D-0789-2022, published May 4, 2022 and initiated April 12, 2022. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 44 Bottles of 90 Tablets 33 Bottles of 30 Tablets; Lot: Lot: E1321O, Exp.: 5/31/2023 Lot: E2521H, Exp.: 5/31/2023 Lot: E2621F, Exp.: 5/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
Nationwide within the U.S to CA, IN and FL.
Lot
Lot: E1321O, Exp.: 5/31/2023 Lot: E2521H, Exp.: 5/31/2023 Lot: E2621F, Exp.: 5/31/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc. recalled?

Yes. FDA published recall D-0789-2022 on May 4, 2022. Reported hazard: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter